These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Morris M; Alvarez RD; Kinney WK; Wilson TO Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553 [TBL] [Abstract][Full Text] [Related]
4. Pelvic exenteration for recurrent endometrial adenocarcinoma: a retrospective multi-institutional study about 21 patients. Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Gallotta V; Margariti AP; Parazzini F; Scambia G; Schneider A; Vercellino GF Int J Gynecol Cancer; 2014 Jun; 24(5):880-4. PubMed ID: 24685828 [TBL] [Abstract][Full Text] [Related]
5. Indications for primary and secondary exenterations in patients with cervical cancer. Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer. Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565 [TBL] [Abstract][Full Text] [Related]
7. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Schmidt AM; Imesch P; Fink D; Egger H Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639 [TBL] [Abstract][Full Text] [Related]
8. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006 [TBL] [Abstract][Full Text] [Related]
9. Pelvic exenterations for gynecological malignancies: a study of 36 cases. Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477 [TBL] [Abstract][Full Text] [Related]
10. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer. Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460 [TBL] [Abstract][Full Text] [Related]
11. Histopathologic tumor spreading in primary ovarian cancer with modified posterior exenteration. Kato K; Nishikimi K; Tate S; Kiyokawa T; Shozu M World J Surg Oncol; 2015 Jul; 13():230. PubMed ID: 26228239 [TBL] [Abstract][Full Text] [Related]